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Dr Joseph Dearani (Rochester, Md). I have no disclosures. The
authorship has provided a well-written article and presentation of
a descriptive review of a large number of adult patients with CHD
who underwent selected procedures at many institutions. Limita-
tions of this review were acknowledged, and this study exemplifies
the strengths and weaknesses of a retrospective review from the
STS database.
Strengths include a large patient cohort of more than 5000
adults with CHD, a growing subspecialty with few data present
in the literature. Most of the data in this review were from the
STS congenital database, and additional data on 3 adult CHD pro-
cedures, 2 common ones being pulmonary valve replacement and
ASD closure, are from the adult STS database. The assumption is
that the majority of procedures in the congenital database were
performed by congenital surgeons; however, it is not clear who
were the primary operators in the adult database, but it is likely
that most were adult surgeons.
The overall early mortality was low at 2%, and not surprisingly
it was highest in the single ventricle group at 11%. These findings
are consistent with other data in the literature. Postoperative mor-
bidity was common, occurring in approximately one third of the
entire group of adults with CHD as you have outlined.
A few findings deserve comment. The early mortality was 2%
for the conduit replacement group, one of the most common pro-
cedures performed in CHD, which is higher than many reports in1096 The Journal of Thoracic and Cardiovascular Surthe literature. This may be because the procedure was not an iso-
lated conduit replacement, was related to the underlying congeni-
tal diagnosis, or in the presence of multiple prior sternotomies. In
the conduit group, 4% had had a stroke preoperatively, which may
have been due to the greater number of prior operations or preex-
isting cyanosis related to palliation before complete repair in the
earlier days of cardiac surgery. The 30% complication rate is
high, particularly with regard to respiratory complications. Con-
duit replacement is generally viewed as a relatively low-risk,
straightforward procedure even in the face of multiple prior oper-
ations. Here it stands out as a procedure with significant morbidity
and the highest early mortality for all of your groups excluding the
Fontan group.
The finding of no early mortality in ASD closure in the congen-
ital database is excellent and sets the gold standard for newer, less-
invasive techniques. However, the ASD repair mortality of 2% to
5% in the adult database, depending on whether it was performed
in isolation or with other procedures, stands out as high. This may
be due in part to improper patient selection or adult surgeons per-
forming congenital operations. The adult STS database also dem-
onstrated a high early mortality of 3.5% for pulmonary valve
replacement. This point deserves emphasis that adult surgeons
should not be performing congenital procedures even if it is a ‘‘sim-
ple ASD closure or pulmonary valve replacement.’’
I commend you and your coauthors for your efforts to examine
a large amount of data and learn more about this difficult and grow-
ing patient population, but it is disappointing there is not a single
statistical analysis with a P value that was performed with 30+ var-
iables in 5000+ patients. This highlights one of the weaknesses of
the STS database, namely, that it is descriptive with some findings
requiring clarification that will go largely unanswered.
I have 3 questions for you.
First, can you clarify why the risk of heart block was highest in
the group of patients undergoing ascending aortic surgery?
Second, can you explain the nature of the arrhythmias and the
arrhythmia procedures that were performed?
Third, what do you think is the most important new finding from
your review that will add to the current literature?
Dr Mascio. To address your first question about heart block in
ascending aortic surgery, I really don’t have a good explanation for
that. It’s one of theweaknesses of the database.We know that a cer-
tain number of ascending aortic aneurysms were done and that
a certain percentage had heart block. Beyond that it’s hard to
know the specifics of individual cases.
The situation is the same for the arrhythmias. There is simply
a box to check whether there is a preoperative arrhythmia or post-
operative arrhythmia. On the basis of the data we collected for this
study, I cannot comment on the type of arrhythmia or if an inter-
vention, surgical or medical, was done.
As far as the most important new finding, I was impressed with
the number of congenital cases done at adult hospitals. I think this
puts an exclamation point on something we all know—that these
patients are trying to find their home. In other words, some seek
care at congenital hospitals. There seems to be no standard formula
for their care yet. Although the STS database is not perfect, it does
provide a snapshot of what’s really going on everywhere.
Dr Rodolfo Neirotti (Cambridge, Mass). I think this is a large
and increasing number of patients who deserve some additionalgery c November 2011
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Dconsiderations. One of them is to try to find and adopt a system of
risk stratification for them. There is a recent article from Rotter-
dam in The Netherlands showing that the current pediatric score
methods are not helpful unless age is added to the formula.
Are you considering or have you used some sort of risk stratifi-
cation score? It could be important to determinewho these patients
are and where they should undergo surgery, particularly those with
higher risk.
This group of patients requires a different business model, a dif-
ferent pathway, and a different mindset. And that is applying to
them the available knowledge on children’s heart diseases in addi-
tion to the mindset of adult care. Do you have some inference and
recommendations regarding this potential business model, path-
way, and mindset for this particular group of patients?
Dr Mascio. To address your first question, I think the next step
should be to start looking at risk stratification. Now that we have an
idea of how many adult patients have complications and what the
overall survival is, it is time to see if we can link pre- or postoper-
ative factors to mortality.
To address your second question as far as business model and
mindset, I would say that complex patients with adult CHD belong
in children’s hospitals or hospitals that take CHD cases. There
have been publications that have indicated a lower in-hospital mor-The Journal of Thoracic and Cartality rate for adults with CHDwhen they undergo operation by pe-
diatric heart surgeons and they’re cared for in CHD centers. That’s
mymindset, and I think that’s what the business model needs to be.
Admitting a Fontan case to a unit that takes care of coronary by-
pass graft cases is not a good plan.
Dr Tara Karamlou (Seattle, Wash). I just wanted to make one
point and then ask one question. I applaud your use of this new
database, because our group has reached similar conclusions us-
ing the Nationwide Inpatient Sample. However, just to empha-
size, I think this current data set is probably not, at least right
now and maybe not for many years, a good one to look at this
population, because from our own literature most of these pa-
tients aren’t cared for in tertiary care settings. I would hypothe-
size that the participants of the congenital database in particular
are probably not the centers where most of these patients are re-
ceiving care.
You alluded to and it’s probably a surrogate for whether it’s a pe-
diatric heart surgeon or an adult-acquired surgeon doing the cases.
Is there a way or do you plan to look at surgeon factors? Because I
think that would be a good use of this data set.
Dr Mascio. We were not able to sort out what type of surgeon
performed the operation and at what type of hospital, but it should
be a part of future studies using the database.diovascular Surgery c Volume 142, Number 5 1097
